ECG Equipment and Management Systems Market Size, Share & Trends Analysis Report By Type (Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems), By End-Use (Hospitals and Clinics, Ambulatory Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Ecg Equipment and Management Systems Market Size

The global ecg equipment and management systems market size was valued at USD 8.27 billion in 2025 and is projected to grow from USD 8.75 billion in 2026 to USD 13.74 billion by 2034, registering a CAGR of 5.8% during the forecast period from 2026 to 2034. North America dominated the ecg equipment and management systems market with a market share of 38.4% in 2025.

ECG (Electrocardiogram) equipment and management systems are crucial to modern cardiac diagnostics and care. ECG equipment comprises electrodes, leads, cables, and a recording device. The electrodes are placed on specific locations of the patient's body to detect and transmit the electrical signals generated by the heart. The leads and cables connect the electrodes to the ECG machine, which records and displays the heart's electrical activity. The ECG machine typically includes a display screen, control buttons or a touchscreen, and internal circuitry for signal processing. Some machines also have built-in printers or digital storage capabilities to document and store the ECG waveform.

One of the key advantages of ECG management systems is their ability to generate comprehensive reports based on the analyzed ECG data. These reports can be customized to include findings, measurements, and annotations, providing valuable insights for healthcare professionals in diagnosing and monitoring cardiac conditions. Moreover, ECG management systems often integrate with electronic health records (EHRs) and other medical information systems, enabling seamless data sharing and continuity of care. This integration streamlines workflows and improves communication among healthcare providers, enhancing patient care and treatment coordination.

Types Insights

The market is bifurcated into holter monitors, resting ECG systems, stress ECG monitors, event monitoring systems, and ECG management systems. The resting ECG systems segment dominates the global market and is projected to exhibit a CAGR of 5.4% over the forecast period. A resting ECG system helps record the heart's electrical activity over a period using electrodes placed on the skin. Factors contributing to the market's growth are improved clinical accuracy because of new product launches, new data analysis tools, and other technology advances and accurate diagnosis.

• For instance, in 2016, GE Healthcare introduced its redesigned Muse system and Mac 2000 resting ECG system at the American College of Cardiology, which enables flexible connectivity. Launched in 2017, the Welch Allyn CP150 resting ECG machine offers a unique 7" touchscreen display for quick results. Partnerships among device manufacturers and device management service providers to develop better exchange of information through Cardiovascular Information Systems (CVIS) and Electronic Health Records (EHRs) to simplify ECG workflow and reduce the complexity associated with custom integration are anticipated to boost market growth.

Request Customizationto receive a tailored report.

End Use Insights

The market is bifurcated into hospitals, clinics, ambulatory facilities, and others. The hospitals and clinics segment dominates the global market and is projected to exhibit a CAGR of 5.8% over the forecast period. The hospital segment accounted for the highest share of the market in 2020, as most patients prefer hospitals over other healthcare facilities due to the availability of well-equipped devices and the latest monitoring software and equipment. Hospitals provide optimal care to patients suffering from cardiovascular diseases, syncope, or arrhythmia and enable early detection and diagnosis, boosting the growth of the ECG Equipment and Management Systems market.

Furthermore, the hospital segment is expected to grow over the forecast period due to the increasing prevalence of cardiac arrhythmias and the rising adoption of Holter devices in hospitals. According to the American Heart Association, Inc., 209,000 patients suffered from in-hospital cardiac arrest in the U.S. in 2016, expected to increase to more than 23.6 million by 2030. According to the WHO, 17.9 million people die annually from cardiovascular diseases. Cardiac arrhythmias have been reported in COVID-19 patients as well. Around 17% of the people who tested COVID-19 positive reported cardiac arrhythmia, according to the latest research report.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global ECG equipment and management systems market shareholder and is estimated to grow at a CAGR of 5.7% over the forecast period. North America dominated the ECG equipment and management systems market in 2020 and is expected to maintain its position during the forecast period. Major factors contributing to its growth are the increasing geriatric population and the prevalence of lifestyle diseases. According to data published by the CDC in June 2020, heart disease accounts for around 647,000 deaths in the U.S. annually. On average, one person dies due to CVD every 37 seconds in the U.S.

Furthermore, the approval and launch of advanced, next-generation ECG equipment and management systems in the U.S. and Canada and high adoption of wearable devices will likely boost the market. Some companies operating in the North American market are Koninklijke Philips N.V., iRhythm Technologies, Inc., GE Healthcare, Spacelabs Healthcare, and Welch Allyn. As per registered Medicare data, there were 4,749 acute care hospitals, children’s hospitals, and critical access hospitals in the U.S. as of December 2016.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Ecg Equipment and Management Systems Market Trends

Europe is anticipated to exhibit a CAGR of 5.9% over the forecast period. The market in Europe is forecasted to expand due to the presence of big industry players and technological developments in wearable monitors for ambulatory monitoring. Furthermore, growing preferences for portable ECG devices with disposable wires stuck to the patient's chest and app-based ECG monitors contribute to market growth.

Furthermore, the increasing incidence of CVDs, the growing geriatric population, and favorable regulatory conditions are expected to boost the market during the forecast period. In Europe, AFib is the most common cardiac arrhythmia among the general population. According to the European Society of Cardiology, 7.6 million people aged 65 years and above had AFib in the EU in 2016, projected to increase by 89% and reach 14.4 million in 2060. The prevalence is estimated to rise from 7.8% to 9.5%, an increase of 22%, during 2016-2060. It is the leading cause of stroke, heart attack, and death.

In Asia-Pacific, large patient populations in China, Japan, and India primarily drive the market. China dominated the Asia-Pacific ECG equipment and market for management systems in terms of revenue share in 2020. This is due to significant market participants locally and the large senior population. The Asia-Pacific region's fastest-growing market is expected to be China throughout the projection period.

The market in Latin America is majorly driven by Brazil, Mexico, Argentina, and Colombia. Increased investments by market players in the region, proximity to North America, and free-trade agreements with major countries, such as the U.S., Canada, Japan, and European countries, are anticipated to boost the market during the forecast period. AFib-associated stroke is one of the major problems in Latin America and is a significant financial and clinical burden. AFib-associated stroke results in a much greater burden on the patient than non-AFib-stroke. According to StopAFib.org, in Venezuela, around 230,000 people are living with AFib, which is likely to reach 1 million by 2050. This, coupled with improving access to the public healthcare system, is driving the market in the region.

Middle Eastern countries have a high frequency of CVDs due to changing lifestyles and food habits. AFib is a common form of cardiac arrhythmia in the region, with an estimated incidence between 1.5% and 2%, and is a major cause of stroke. Nearly 30% of school-going children are obese in the Middle East, and the number of CVD patients is increasing. The overall population suffering from AFib in the Middle East is younger and has more comorbidities than patients in the West.

List of Key and Emerging Players in ECG Equipment and Management Systems Market